In the last trading session, 1.05 million Emergent Biosolutions Inc (NYSE:EBS) shares changed hands as the company’s beta touched 2.11. With the company’s per share price at $6.49 changed hands at -$0.14 or -2.11% during last session, the market valuation stood at $352.26M. EBS’s last price was a discount, traded about -132.67% off its 52-week high of $15.10. The share price had its 52-week low at $4.02, which suggests the last value was 38.06% up since then.
Analysts gave the Emergent Biosolutions Inc (EBS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.33. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended EBS as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Emergent Biosolutions Inc (NYSE:EBS) trade information
Instantly EBS was in red as seen at the end of in last trading. With action 3.02%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -32.11%, with the 5-day performance at 3.02% in the green. However, in the 30-day time frame, Emergent Biosolutions Inc (NYSE:EBS) is 2.04% up.
The consensus price target for the stock as assigned by Wall Street analysts is 51.5, meaning bulls need an upside of 87.4% from its current market value. According to analyst projections, EBS’s forecast low is 38 with 65 as the target high. To hit the forecast high, the stock’s price needs a -901.54% plunge from its current level, while the stock would need to soar -485.52% for it to hit the projected low.
The 2025 estimates are for Emergent Biosolutions Inc earnings to increase by 469.57%.
EBS Dividends
Emergent Biosolutions Inc is expected to release its next quarterly earnings report in July.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 6.97% or 3.67 million shares worth $25.0 million as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were American Century ETF Trust-Avantis U.S. Small Cap Value ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 1.94 shares estimated at $12.6 million under it, the former controlled 3.58% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.90% of the shares, roughly 1.57 shares worth around $10.21 million.
